Literature DB >> 17964407

Nepafenac-associated corneal melt.

Eric Jay Wolf1, Lynda Z Kleiman, Amilia Schrier.   

Abstract

We describe a patient with systemic graft-versus-host disease who developed a nonhealing epithelial defect after cataract surgery that healed on cessation of a topical nonsteroidal antiinflammatory drug (NSAID) (ketorolac). The patient developed a central corneal perforation in the fellow eye while on a new NSAID formulation (nepafenac) after routine cataract surgery. Our case suggests that new topical NSAIDs may be similar to older NSAID formulations in promoting corneal melting in patients predisposed to poor epithelialization and corneal wound healing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964407     DOI: 10.1016/j.jcrs.2007.06.043

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  Stromal lenticule transplantation for management of corneal perforations; one year results.

Authors:  Mohamed Samy Abd Elaziz; Adel Galal Zaky; Abdel Rahman El SaebaySarhan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-13       Impact factor: 3.117

2.  Cataract surgery in patients with ocular surface disease: An update in clinical diagnosis and treatment.

Authors:  Neda Afsharkhamseh; Asadolah Movahedan; Hooman Motahari; Ali R Djalilian
Journal:  Saudi J Ophthalmol       Date:  2014-07-04

3.  The use of topical nalbuphine in different concentrations to control pain after photorefractive keratectomy.

Authors:  Hala Kamal Mattout; Sameh Mosaad Fouda
Journal:  Int Ophthalmol       Date:  2022-01-12       Impact factor: 2.029

Review 4.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

5.  Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension.

Authors:  Bruce I Gaynes; Anne Onyekwuluje
Journal:  Clin Ophthalmol       Date:  2008-06

6.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome.

Authors:  Humaira Ansari; Laurence Weinberg; Narelle Spencer
Journal:  BMJ Case Rep       Date:  2013-09-13

8.  Cystoid macular edema associated with iridocorneal endothelial syndrome: a case report.

Authors:  Keita Suzuki; Tadashi Mizuguchi; Yui Seno; Atsuhiro Tanikawa; Masayuki Horiguchi
Journal:  BMC Ophthalmol       Date:  2016-09-01       Impact factor: 2.209

9.  Central corneal melting associated with reformulated generic diclofenac in a patient with inferior fornix foreshortening.

Authors:  Cameron Campbell Johnson
Journal:  Ophthalmol Eye Dis       Date:  2011-07-25

10.  Corneal Melting after Collagen Cross-Linking for Keratoconus in a Thin Cornea of a Diabetic Patient Treated with Topical Nepafenac: A Case Report with a Literature Review.

Authors:  Karim Mohamed-Noriega; Karla Butrón-Valdez; Jeronimo Vazquez-Galvan; Jibran Mohamed-Noriega; Humberto Cavazos-Adame; Jesús Mohamed-Hamsho
Journal:  Case Rep Ophthalmol       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.